Chromogenic absorbent material for animal litter and related chromogenic solution
09547000 ยท 2017-01-17
Assignee
Inventors
Cpc classification
G01N33/543
PHYSICS
C09B67/0097
CHEMISTRY; METALLURGY
G01N33/52
PHYSICS
International classification
G01N33/52
PHYSICS
A01K1/015
HUMAN NECESSITIES
Abstract
A chromogenic absorbent material and related chromogenic solution, use, process and application for an animal litter. The chromogenic absorbent material includes an absorptive material for absorbing an animal excretion; an oxidizing agent responsive to peroxidatic/pseudoperoxidatic activity in the animal excretion to provide oxidizing activity; and an inclusion complex including a host compound and a guest compound, the guest compound being a chromogenic indicator associated with the host compound and being chromogenically responsive to the oxidizing activity of the oxidizing agent. The chromogenic absorbent material may be prepared from the chromogenic solution including the oxidizing agent and the inclusion complex. The chromogenic absorbent material may be used as particles combined with animal litter for detection of peroxidatic/pseudoperoxidatic activity in the animal excretion. The chromogenic material or solution may include a buffering agent, a colour enhancer, a stabilizer or a metal-scavenger agent or a combination thereof.
Claims
1. A chromogenic absorbent material for an animal litter, the chromogenic absorbent material comprising: an absorptive material for absorbing an animal excretion; an oxidizing agent responsive to peroxidatic/pseudoperoxidatic activity in the animal excretion to provide oxidizing activity; and an inclusion complex including a host compound and a guest compound, the guest compound being a chromogenic indicator associated with the host compound and being chromogenically responsive to the oxidizing activity of the oxidizing agent.
2. The chromogenic absorbent material of claim 1, wherein the absorptive material comprises a polysaccharide.
3. The chromogenic absorbent material of claim 2, wherein the polysaccharide comprises starch, modified starch, amylopectin, modified amylopectin, amylose, modified amylose, cellulose or cellulosic fibers or a combination thereof.
4. The chromogenic absorbent material of claim 1, wherein the host compound comprises hydroxypropyl-alpha-cyclodextrin, 2-hydroxypropyl-beta-cyclodextrin, hydroxypropyl-gamma-cyclodextrin or a combination thereof.
5. The chromogenic absorbent material of claim 1, wherein the oxidizing agent comprises a hydroperoxide, a hydroperoxide precursor or a combination thereof.
6. The chromogenic absorbent material of claim 1, wherein the chromogenic indicator comprises a benzidine-type compound.
7. A chromogenic absorbent material for an animal litter, the chromogenic absorbent material comprising: an absorptive material comprising a first polysaccharide, for absorbing an animal excretion; a second polysaccharide comprising cellulose, cellulosic fibers, an oligosaccharide or a mixture thereof; an oxidizing agent responsive to peroxidatic/pseudoperoxidatic activity in the animal excretion to provide oxidizing activity; and a chromogenic indicator being chromogenically responsive to the oxidizing activity of the oxidizing agent; wherein the second polysaccharide and the chromogenic indicator form an inclusion complex.
8. The chromogenic absorbent material of claim 7, wherein the first polysaccharide comprises starch, modified starch, amylopectin, modified amylopectin, amylose, modified amylose or a combination thereof.
9. The chromogenic absorbent material of claim 7, wherein the first polysaccharide comprises pre-gelatinized starch, glass-like starch, waxy starch, anionic starch, cationic starch, fractionated starch, cross-linked starch, hydroxyalkylated starch, alkylated starch, or a mixture thereof.
10. The chromogenic absorbent material of claim 7, wherein the first polysaccharide comprises pre-gelatinized starch.
11. The chromogenic absorbent material of claim 7, wherein the second polysaccharide comprises cellulose.
12. The chromogenic absorbent material of claim 7, wherein the oligosaccharide comprises hydroxypropyl-alpha-cyclodextrin, 2-hydroxypropyl-beta-cyclodextrin, hydroxypropyl-gamma-cyclodextrin or a combination thereof.
13. The chromogenic absorbent material of claim 7, wherein the oxidizing agent comprises cumene hydroperoxide, diisopropylbenzene dihydroperoxide or a combination thereof.
14. The chromogenic absorbent material of claim 7, wherein the chromogenic indicator comprises a benzidine-type compound.
15. The chromogenic absorbent material of claim 14, wherein the benzidine-type compound comprises 3,3,5,5-tetramethylbenzidine.
16. The chromogenic absorbent material of claim 7, further comprising a buffering agent, a stabilizer, a metal-scavenger agent, a color enhancer or a combination thereof.
17. The chromogenic absorbent material of claim 16, wherein the color enhancer comprises 6-methoxyquinoline, lepidin, phenol derivatives, nitrobenzene, N-methylpyrrolidone, ethylene carbonate or a combination thereof.
18. The chromogenic absorbent material of claim 16, wherein the stabilizer comprises ammonium molybdate, polyethylene glycol, polyvinylpyrrolidone, polyethylene oxide or derivatives thereof or a combination thereof.
19. Particles of the chromogenic absorbent material as defined in claim 7, the particles of the chromogenic absorbent material being used in combination with or as animal litter.
20. An animal litter material for detecting peroxidatic/pseudoperoxidatic activity in an animal excretion, the animal litter material comprising the chromogenic absorbent material as defined in claim 7.
21. The chromogenic absorbent material of claim 7, wherein the second polysaccharide has a frusto-conical configuration, and wherein the inner space of the frusto-conical configuration enables trapping and stabilizing of the chromogenic indicator.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) Embodiments of the chromogenic absorbent material and related chromogenic solution, use and process according to the present invention are represented in and will be further understood in connection with the following figures.
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11) While the invention will be described in conjunction with example embodiments, it will be understood that it is not intended to limit the scope of the invention to such embodiments. On the contrary, it is intended to cover all alternatives, modifications and equivalents as may be included as defined by the present description. The advantages and other features of the present invention will become more apparent and be better understood upon reading of the following non-restrictive description of the invention, given with reference to the accompanying drawings.
DETAILED DESCRIPTION
(12) The present invention provides a chromogenic solution and related chromogenic absorbent material for detecting blood in excretions. More particularly, the chromogenic absorbent material may be used in connection with an animal litter.
(13) It should be understood that excretion refers to any matter excreted by an animal, such as urine or fecal matter. The chromogenic absorbent material may be used in any domestic animal litter including cat, dog litter and rodent litter. It may also be used for horse litter, cow litter or any other livestock litter. However, the present invention is not limited to detecting blood in animal excretions and may be used to detect blood in human excretions for example. The chromogenic solution may be applied to non-woven absorptive material, such as pads for this purpose.
(14) In one aspect, the present invention relates to particles of chromogenic absorbent material that may be dispersed within the animal litter or at the surface of the animal litter.
(15) In one aspect of the present invention, each particle of chromogenic absorbent material includes: an absorptive material; an oxidizing agent responsive to peroxidatic/pseudoperoxidatic activity in excretions; and an inclusion complex including a host compound and a guest compound, the guest compound being a chromogenic indicator associated within the host compound, and the chromogenic indicator being responsive to the oxidizing agent,
the oxidizing agent and the inclusion complex being distributed on at least an exterior surface of the absorptive material.
(16) It should be understood that the expression the chromogenic indicator responsive to the oxidizing agent means that the chromogenic indicator may change colour upon response of the oxidizing agent to peroxidase or pseudoperoxidase activity in excretions. Peroxidase or pseudoperoxidase are enzymes (hemoproteins) naturally present in blood and catalyzing the oxidation of peroxides, such as hydrogen peroxide, of a number of substrates such as ascorbate, ferrocyanide, cytochrome C and the leuco form of many dyes.
(17) It should be understood that the expression peroxidatic activity refers to the ability of catalytic substances to drive the reaction of hydroperoxides with colorless chromogenic electron donors which become fluorescent or visibly colored after oxidation.
(18) It should be understood that the expression pseudoperoxidatic activity refers to the ability of a peroxidase or a non-peroxidase catalytic substance to drive the reaction of hydroperoxidases with colorless chromogenic electron donors which become fluorescent or visibly colored after oxidation. Certain transition metals and their ions and hemoproteins are known to have pseudoperoxidatic activity. Basophils, neutrophils, eosinophils and mast cells synthesize endogenous peroxidase which can be visualized at the ultrastructural level in the secretory apparatus of immature cells. Red blood cells and hematin containing compounds have iron as part of their heme groups, which can catalyze the oxidation of chromogenic electron donors. This pseudoperoxidatic activity can be inhibited with strong H.sub.2O.sub.2 solutions, sodium azide and methanol-H.sub.2O.sub.2 solutions.
(19) It should be understood that particle refers to any pellet, granule or piece of various shapes. Optionally, circular particles may have an average diameter ranging from 2.5 mm to 10 mm. Optionally, square or rectangular particles may have an average length ranging from 5 mm to 20 mm. Optionally, the particles may have a top surface ranging from 19 mm.sup.2 to 400 mm.sup.2 and a thickness ranging from 1 to 10 mm. The shape of the particles is conferred by their process of manufacture.
(20) In an optional aspect, the absorptive material may be polymeric and optionally includes a polysaccharide, which provides polysaccharide chain backbones in addition to a general polysaccharide matrix. More particularly, polysaccharides may be starches, modified starches, amylopectin, modified amylopectin, amylose, modified amylose or mixture thereof. Amongst these polysaccharides, starch is frequently chosen as a polysaccharide for use in the agglomerated particle. Non-limiting examples of such starches are starch granules, pre gelatinized starches, glass-like starches, waxy starches, anionic starches, cationic starches, fractionated starches, cross-linked starches, hydroxyalkylated starches, alkylated starches and mixture thereof. Starch that is suitable for the present invention may be obtained from many sources, including but not limited to wheat, maize, buckwheat, potato, cassaya, sorghum, millet, oat, arrowroot, barley, beans, peas, rice, rye, waxy starches and mixture thereof. A commonly used starch is wheat starch. Naturally occurring starch is usually organized in a semi-crystalline, water insoluble pattern, which is sometimes referred to as a starch granule. The form of these starch granules is characteristic of their botanical origin, and their mean particle size may range from about 1 m to about 60 m. The absorptive material may also include cellulose or cellulosic fibers issued from paper, recycled paper or paper sludge. The cellulose might also be from refined pulp, such as wood pulp and from any vegetal origin, such as wheat, products derived from wheat, corn, products derived from corn, bamboo, pine wood, birch wood, poplar, eucalyptus or combination thereof. The absorptive material may optionally include perlite glass.
(21) The oxidizing agent is reactive to peroxidatic/pseudo-peroxidatic activity and is able to activate the chromogenic indicator contained in the inclusion complex. The oxidizing agent oxidizes the chromogenic indicator in presence of the enzymes peroxidase or pseudo-peroxidase. In an optional aspect, the oxidizing agent includes a hydroperoxide. Hydroperoxides may be, for example, cumene hydroperoxide which is suitable for detection of peroxidatic/pseudoperoxydatic activity. Additionally, cumene hydroperoxide can have some reactivity to elevated glucose levels.
(22) Hydroperoxides are therefore suited for detection of urinary tract diseases. The hydroperoxide may also be, for example, diisopropylbenzene dihydroperoxide which has high selectivity to detection of peroxidatic/pseudoperoxydatic activity and thus of urinary tract disease. In an optional aspect, a combination of the previously mentioned hydroperoxides may be used in the chromogenic composition for selectively detecting several diseases in excretions. Optionally, the oxidizing agent may be a hydroperoxide precursor such as sodium percarbonate. Sodium percarbonate is a solid which decomposition forms hydrogen peroxide in presence of water.
2Na.sub.2CO.sub.2.3H.sub.2O.sub.2.fwdarw.2Na.sub.2CO.sub.33H.sub.2O.sub.2
(23) It should be understood that hydroperoxide refers to compounds of the general formula, ROOH, wherein the R group is an aryl, alkyl, or acyl group (organic hydroperoxide), or hydrogen atom (hydrogen peroxide).
(24) The oxidizing agent, triggered by the presence of peroxidatic/pseudoperoxidatic activity in excretions, oxidizes the chromogenic indicator which therefore changes of color. More particularly, the chromogenic indicator is an electron donor, i.e. a reducing agent that changes color upon losing an electron.
(25) In an optional aspect, the host agent of the inclusion complex may be a cyclic oligosaccharide, such as hydroxypropyl-alpha-cyclodextrin, hydroxypropyl-beta-cyclodextrin (2HPCD), hydroxypropyl-gamma-cyclodextrin or any combination thereof. The host agent of the inclusion complex may be a branched hydroxypropyl-beta-cyclodextrin or sulfobutyl-ether hydroxypropyl-beta-cyclodextrin sodium salt. Further details on the inclusion complex will be provided herebelow with description of embodiments of a chromogenic solution and related process of manufacture.
(26) In an optional aspect, the chromogenic indicator may be a benzidine-type compound, i.e. a compound as shown in Formula I:
(27) ##STR00001##
(28) In Formula I, groups R.sub.1, R.sub.2, R.sub.3 and R.sub.4 may be the same or different and may be hydrogen, halogen, a lower alkyl or alkoxy group containing 1 to 4 carbon atoms, a (C.sub.1-C.sub.4)-dialkylamino group, an acetylamino group, a nitro group or an aromatic group which may be substituted.
(29) Optionally, the chromogenic indicator may be a compound as shown in Formula II:
(30) ##STR00002##
(31) In Formula II, groups R.sub.1, R.sub.2, R.sub.3 and R.sub.4 may be the same or different and represent hydrogen, halogen, and a lower alkyl or alkoxy group containing 1 to 4 carbon atoms, a (C.sub.1-C.sub.4)-dialkylamino group, an acetylamino group, a nitro group or an aromatic group which may be substituted; R.sub.5 and R.sub.6 are the same or different and represent water-soluble groups as hydroxyl groupl, amino group, acidic group, disulfonyl group, ether group, halogen, and a lower alkyl or alkoxy group containing 1 to 4 carbon atoms, a (C.sub.1-C.sub.4)-dialkylamino group, an acetylamino group or a nitro group.
(32) Thus, a water soluble benzidine-type chromogenic indicator of Formula II, responds in the presence of hydroperoxide and peroxidase by changing its light absorptive capability, which is due to the chemical transformation to the compound shown in Formula III:
(33) ##STR00003##
(34) Several different types of benzidine chromogenic indicators may be used in optional embodiments of the present invention.
(35) Optionally, the chromogenic indicator may be 3,3,5,5-tetramethylbenzidine (TMB). TMB is a colorless agent which turns blue upon oxidation. The peroxidase/pseudo-peroxidase enzymes catalyze the oxidation of TMB by the oxidizing agent (hydroperoxide) according to the following oxidation reaction:
(36) ##STR00004##
(37) In an optional aspect, the chromogenic absorbent material may turn blue upon contact with excretions containing at least traces of blood (with therefore peroxidase/pseudo-peroxidase activity).
(38) It should be understood that blue refers to any shade of blue. The chromogenic absorbent material may need a contact time with excretions sufficient to enable coloration. In an optional aspect, the particles may turn blue after a contact time ranging from about 1 min to about 30 min depending on the nature of the absorptive material of the particles.
(39) In another optional aspect, the chromogenic absorbent material may turn to different shades of blue depending on the blood concentration in excretions. The intensity of the blue shade may be proportional to the blood concentration in excretions. The chromogenic absorbent material offers an easy and accurate blood test that may indicate the blood concentration in the excretions.
(40) Experiments have been performed by depositing an aqueous blood solution of various blood concentrations on pieces of chromogenic absorptive paper and chromogenic pellets of wheat starch. The chromogenic absorptive paper has been prepared by spraying 100 g to 500 g of chromogenic solution per kg of absorptive paper. The chromogenic pellets of wheat starch have been prepared by extruding and heating wheat starch for gelatinization thereof with 0.2 to 1.2 kg of chromogenic solution per kg of wheat starch, optionally 0.3 to 0.5 kg. The extruded pellets were oven dried at 60 C. Several blood concentrations (volumic mass of blood per total volume of aqueous blood solution) were tested from 0.0001% to 1%. More particularly, referring to
(41) Referring to
(42) In an optional aspect, the nature and form of the absorptive material may be selected and modified to allow sufficient internal diffusion and retention of excretions to facilitate the chromogenic indicator response over time. For example, the absorptive material may be modified so as to increase its porosity. The chromogenic indicator may also be homogeneously dispersed throughout the absorptive material according to the preparation method of the chromogenic absorbent material. The chromogenic indicator may be present not only at the exterior surface of a given particle, but also in a neighboring sub-surface region that can be rapidly exposed to excretions that absorbs into the particle. Additionally, when the absorptive material is glassy or substantially transparent, the presence of the chromogenic indicator in a sub-surface region allows it to be readily visible when color change occurs and also avoids exposure to the air.
(43) In an optional aspect, the chromogenic composition may further include a colour enhancer. Optionally, it may also include a buffering agent, a stabilizer, a metal scavenger agent or a combination thereof. The colour enhancer may optionally be 6-methoxyquinoline, lepidin, phenol derivatives, nitrobenzene, N-methylpyrrolidone, ethylene carbonate or any combination thereof. The buffering agent may optionally include citrate, sodium citrate, phosphate, acetate or any combination thereof. The stabilizer may optionally be ammonium molybate and derivatives thereof, polyethylene glycol, polyvinylpyrrolidone, polyethylene oxide and derivatives thereof, or combination thereof. The metal-scavenger agent may optionally be EDTA, EDTA sodium salt or any combination thereof.
(44) Advantageously, the particles of chromogenic absorbent material offer an easy, reliable and efficient way to detect blood in animal excretion when used in combination with animal litter. Particles may be provided as a separate additive to animal litter for the purpose of being mixed to conventional animal litter when the animal excretions need to be tested. Particles may also be provided pre-mixed directly with conventional animal litter in a packaged litter formula for sale.
(45) In another aspect, the present invention relates to a chromogenic solution including: a solvent; an oxidizing agent responsive to peroxidatic/pseudoperoxidatic activity in excretions; an inclusion complex soluble in the solvent and including a host compound and a guest compound, the guest compound being a chromogenic indicator associated within the host compound, and the chromogenic indicator being responsive to the oxidizing agent.
(46) Optionally, the chromogenic solution may include a buffering agent so as to maintain a pH of the chromogenic solution between 5 and 7. Extreme pH may be avoided.
(47) Optionally, the chromogenic solution may include a colour enhancer, a stabilizer, a metal-scavenger agent or a combination thereof as defined above.
(48) In another aspect, the present invention relates to the use of the above-mentioned chromogenic solution for association with an absorptive material so as to form the chromogenic absorbent material.
(49) It should be understood that each of the above-mentioned aspect in relation to the inclusion complex and oxidizing agent included in the chromogenic composition may be adapted to aspects of the inclusion complex and oxidizing agent included in the chromogenic solution.
(50) In another aspect, the present invention relates to the use of an inclusion complex in animal litter for chromogenic indication of peroxidatic/pseudoperoxidatic activity in excretions. The inclusion complex includes a host compound and a guest compound associated within the host compound. The chromogenic indicator is the guest compound of the inclusion complex. The use of a host compound for association with the chromogenic indicator enables to form an inclusion complex which has a superior solubility in the solvent than the chromogenic indicator alone. Advantageously, a chromogenic indicator which was not soluble or not enough soluble into a specific solvent becomes soluble in that same solvent because of the inclusion complex acting as a vessel for the chromogenic indicator. For example, as TMB (chromogenic indicator) is slightly soluble in water, an inclusion complex can be formed with 2HPCD (host compound), which is water-soluble. Aqueous solutions using water as solvent may therefore be used instead of organic solvents. The chromogenic solution may be therefore prepared without the use of organic solvent for the benefit of workers and environment. Indeed, organic solvents may cause environmental problems such as air pollution, water and soil contamination, as well as being harmful to wildlife. When preparing a solution with organic solvent, workers are also exposed to various hazards, such as risks of fire and poisoning, skin damage, eye injury and nervous system disorders. Animal may further dislike the odors of solvents and discourage them from using the litter.
(51) Referring to
(52) The solubility of the inclusion complex TMB-2-HPCD in non-organic solvent is about ten times greater compared to the solubility of isolated TMB. The following Table 1 presents results regarding the solubility of TMB in different solvents.
(53) TABLE-US-00001 TABLE 1 SOLVENT SOLUBILITY (mM) Dimethylsulfonamide 1.6 Methanol 5.2 Ethyl acetate 10 Water 0.1
(54) Consequently, the chromogenic absorbent material includes a higher concentration of inclusion complexes and is more color responsive when contacted by blood. Indeed, upon contact with blood in excretions, more TMB is available for oxidation and the color response is enhanced. The detection may therefore be more accurate and blood-sensitive in comparison to existing chromogenic material for litters. In an optional aspect, a perceptible coloration may appear when the chromogenic absorbent material is contacted with blood at a concentration of at least 100 red cells per L in excretions (also referred to as blood concentration threshold). In an optional aspect, the chromogenic solution may have a concentration of oxidizing agent ranging between 0.1 wt % to 0.5 wt % (mass of oxidizing agent with respect to the total mass of the solution). The chromogenic solution may have a concentration of inclusion complex ranging between 1 wt % and 50 wt %. Preferably, the chromogenic solution may have a concentration of inclusion complex between 4 wt % and 25 wt %.
(55) In another aspect, the present invention relates to a process for preparing a chromogenic solution for application in connection to the above-mentioned chromogenic absorbent material. The preparation process includes the following steps: preparation of a base solution by addition of a host compound into a solvent; addition of a chromogenic agent to the base solution so as to form a solvent-soluble inclusion complex including the host compound and the chromogenic agent as a guest compound associated with the host compound; and addition of an oxidizing agent to form the chromogenic solution, the oxidizing agent oxidizing the chromogenic agent in presence of peroxidatic/pseudoperoxidatic activity in excretions.
(56) In an optional aspect, the chromogenic solution may include a ratio between 5 and 60 of total weight of host compound over total weight of chromogenic indicator. For example, the molar ratio of TMB over 2HPCD, considering a molar mass of 1541 g/mol for the 2HPCD, may be between 1/10 and 1/1. Preferably, this molar ratio may be between 1/7.5 and 1/1. Experiments have shown that a molar ratio of 1/1 rapidly produces a deep blue coloration of TMB when oxidized (cf. Example 3).
(57) In an optional aspect, the process may include an addition of a buffering agent, a color enhancer, a stabilizer, an anti-metal agent or a combination thereof. The anti-metal agent may be used to precipitate metallic ions, such as ferric ions, that are possibly present in solution and avoid reaction with the chromogenic indicator.
(58) In an optional aspect, the chromogenic solution may be prepared and tailored to the particular absorptive material.
(59) In another aspect, the present invention relates to a process for manufacturing a chromogenic absorbent material as defined above. The manufacturing process includes combining an absorptive material with a chromogenic solution so as to form the chromogenic absorbent material. The absorptive material may be provided as a plurality of particles as defined above.
(60) Referring to
(61) Optionally, the chromogenic solution may be sprayed onto a surface of the absorptive material. The spraying technique may be suited for absorptive material such as paper or perlite. Alternatively, the chromogenic solution may be added in a mixer to the particles of absorptive material for impregnation thereof.
(62) In an optional aspect, the process may include the formation of the absorptive material before combination with the chromogenic solution. The absorptive material may be formed by extrusion, impregnation, pressure agglomeration or tumble growth agglomeration.
(63) Optionally, the chromogenic solution may be added to a gelled absorptive material in an extruder. When used in combination to extruded material, the solution may be added in an early stage of the extrusion process during mixing of the components of the absorptive material at a temperature ranging from 70 to 80 C. Alternatively, when used in combination to extruded material, the solution may be added during final stage of extrusion when heat and shear treatment are minimized and the temperature is sufficiently low such that the chromogenic and oxidizing agent do not degrade or deactivate due to high temperature.
(64) For example, the chromogenic solution may be injected at a point near the exit of the extruder such that the absorptive material has formed a gelled matrix and the components in the chromogenic solution are quickly dispersed within the gelled matrix prior to exiting the extruder.
(65) Optionally, before exiting the extruder, the absorptive material may be injected with a gaseous stream so as to increase the porosity of the extruded particles and therefore increase their contact surface with excretions. One difficulty of the extruding technique, however, is that the process temperature can lead to the degradation or reaction of the oxidizing agent. Thus, for such embodiments, the absorptive material should be handled carefully at reduced temperatures, using stabilizing additives, or choosing oxidizing agents that do not react at the processing conditions, such that the oxidizing agents remain active in the final chromogenic absorbent material.
EXAMPLES
Example 1
(66) Experiments have been performed by soaking paper solid matrix with 100 to 500 g of chromogenic solution per kilogram of paper. The chromogenic solution used for this purpose is detailed in Table 2:
(67) TABLE-US-00002 TABLE 2 Massic Molar Concen- concen- Mass tration Ratio/ tration % Compound (g/mol) (mMol) TMB() (g/L) m/m Water (solvent) 1000.00 74.27 2HPCD (host compound) 1541.00 200.00 7.5 308.20 22.89 TMB (chromogenic 240.34 26.67 6.41 0.48 indicator) Sodium citrate 294.10 56.92 16.74 1.24 Citric acid (buffering agent) 192.12 40.00 7.68 0.57 EDTA (stabilizer) 372.24 4.00 0.15 1.49 0.11 Cumene hydroperoxide 152.19 13.33 0.5 2.03 0.15 (oxidizing agent) Lepidine (color enhancer) 143.19 26.67 1 3.82 0.28
(68)
Example 2
(69) Experiments have been performed by soaking extruded wheat starch pellets with an amount of aqueous solution having a 0.0215% concentration in blood, or with the same amount of synthetic urine. The wheat starch pellets were prepared by extruding wheat starch and injecting 0.28 kg of the chromogenic solution by kg of wheat starch at the beginning of the extrusion process.
(70)
Example 3
(71) Experiments have been also been performed to evaluate the influence of the mass ratio TMB/2HPCD on the blue coloration when substrate is contacted by blood solution. Four chromogenic solutions have been prepared with a ratio of 1/1 or 1/7.5 as indicated in Table 3. The molar concentrations and mass percentage of 2HPCD and TMB in each of the four solutions are respectively given in Table 4 and Table 5. These chromogenic solutions were used to prepare chromogenic absorbent paper which was soaked with a 0.0215% blood solution.
(72) TABLE-US-00003 TABLE 3 CHROMOGENIC SOLUTION RATIO TMB/2HPCD 1 1/7.5 2 1/1.sup. 3 1/7.5 4 1/1.sup.
(73) TABLE-US-00004 TABLE 4 Sodium Citric Cumene Component Water 2HPCD TMB citrate acid hydroperoxide Lepidine Molar mass 18.01 1541.00 240.34 294.10 192.12 152.19 143.19 (g/mol) Concentration in 200.00 26.67 56.92 40.00 13.33 26.67 solution 1 (mMol) Concentration in 26.67 26.67 56.92 40.00 13.33 26.67 solution 2 (mMol) Concentration in 63.75 8.50 56.92 40.00 4.25 8.50 solution 3 (mMol) Concentration in 8.50 8.50 56.92 40.00 4.25 8.50 solution 4 (mMol)
(74) TABLE-US-00005 TABLE 5 Components (in molar mass percentage) Solution 1 Solution 2 Solution 3 Solution 4 Water 74.27 92.66 88.65 95.89 2HPCD 22.89 3.81 8.71 1.26 TMB 0.48 0.59 0.18 0.20 Sodium citrate 1.24 1.55 1.48 1.60 Citric acid 0.57 0.71 0.68 0.74 Cumene 0.15 0.19 0.06 0.06 hydroperoxide Lepidine 0.28 0.35 0.11 0.12
(75)